HIV Clinical Trial
— NOURISH-OKOfficial title:
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
The NOURISH-OK Study will identify how food insecurity contributes to insulin resistance, an important surrogate marker of many co-morbidities in HIV disease, using an integrated framework to identify key leverage points for insulin resistance. Drawing from these pathways, this study will adapt and evaluate a community-driven, science-informed "food as medicine" intervention designed to lower insulin resistance through healthy food access, food utilization skills, and other self-care behaviors. Knowledge gained from this study can benefit those living with HIV through the prevention and more effective management of pre-diabetes, diabetes, obesity, and non-alcoholic fatty liver disease.
Status | Recruiting |
Enrollment | 234 |
Est. completion date | December 2025 |
Est. primary completion date | May 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - HIV-positive with income <400% federal poverty level - at least 1 risk factor for insulin resistance per the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (i.e., overweight/obesity, age 45 yrs or older, immediate family member with diabetes, non-white race, physical inactivity, history of gestational diabetes, history of heart disease or stroke, diagnosis of polycystic ovarian syndrome, high blood pressure, high cholesterol, or hepatitis C virus antibody positivity - using antiretroviral therapy for at least 6 months - English-speaking Exclusion Criteria: - participating in another health-related research study - receiving treatment for a terminal or other serious illness, such as cancer or end-stage renal failure - plan to move outside of Oklahoma during the study period - does not have an address that can accept home-delivered groceries |
Country | Name | City | State |
---|---|---|---|
United States | OU Integrative Immunology Center | Tulsa | Oklahoma |
Lead Sponsor | Collaborator |
---|---|
University of Oklahoma | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change from baseline gut microbiome composition at 12-weeks | Microbiome composition (diversity) - subsample only | Baseline; 12-weeks | |
Primary | Change from baseline insulin sensitivity at 12-weeks | Quantitative Insulin-Sensitivity Check Index (QUICKI) | Baseline; 12-weeks | |
Secondary | Change from baseline food security at 6-weeks, 12-weeks, and 16-weeks | 10-item US Adult Food Security Module (0-10 point range; higher score reflects lower food security) | Baseline; 6-weeks; 12-weeks; 16-weeks | |
Secondary | Change from baseline dietary intake at 6-weeks, 12-weeks, and 16-weeks | Dietary Inflammatory Index (DII) (higher score reflects diet with greater inflammatory potential) | Baseline; 6-weeks; 12-weeks; 16-weeks | |
Secondary | Change from baseline skin carotenoid at 12-weeks | reflection spectroscopy using "Veggie Meter" device (higher score reflects higher carotenoid status) | Baseline; 12-weeks | |
Secondary | Change from baseline chronic inflammation at 12-weeks | C-reactive protein (blood measure) (higher score reflects higher chronic inflammation) | Baseline; 12-weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |